Not everyone responds at the same milligram amount
Comparison of canine and human physiological factors: understanding interspecies differences that impact drug pharmacokinetics,, 23
Several clinical trials are underway to discover why GLP-1 users with disorders and addiction report diminished cravings, though scientists have suggested a theory that the medications may interact with parts of the brain that produce dopaminealso known as the feel-good hormone, which has been linked to addictionin a way that makes the dopamine effects of drugs and alcohol less intense
Global regulatory agencies, including the US Food and Drug Administration (FDA), European Medicines Agency, and World Health Organization (WHO), have warned about fake versions driven by patient demand, high cost, and shortages
Regulatory changes could restrict compounding access further
They do not provide the pigment suppression and antioxidant benefits of glutathione, which is also gentler, but the two work well together